1
|
Rupprecht CE, Buchanan T, Cliquet F, King R, Müller T, Yakobson B, Yang DK. A Global Perspective on Oral Vaccination of Wildlife against Rabies. J Wildl Dis 2024; 60:241-284. [PMID: 38381612 DOI: 10.7589/jwd-d-23-00078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2023] [Accepted: 01/03/2024] [Indexed: 02/23/2024]
Abstract
The long-term mitigation of human-domestic animal-wildlife conflicts is complex and difficult. Over the last 50 yr, the primary biomedical concepts and actualized collaborative global field applications of oral rabies vaccination to wildlife serve as one dramatic example that revolutionized the field of infectious disease management of free-ranging animals. Oral vaccination of wildlife occurred in diverse locales within Africa, Eurasia, the Middle East, and North America. Although rabies is not a candidate for eradication, over a billion doses of vaccine-laden baits distributed strategically by hand, at baiting stations, or via aircraft, resulted in widespread disease prevention, control, or local disease elimination among mesocarnivores. Pure, potent, safe, and efficacious vaccines consisted of either modified-live, highly attenuated, or recombinant viruses contained within attractive, edible baits. Since the late 1970s, major free-ranging target species have included coyotes (Canis latrans), foxes (Urocyon cinereoargenteus; Vulpes vulpes), jackals (Canis aureus; Lupulella mesomelas), raccoons (Procyon lotor), raccoon dogs (Nyctereutes procyonoides), and skunks (Mephitis mephitis). Operational progress has occurred in all but the latter species. Programmatic evaluations of oral rabies vaccination success have included: demonstration of biomarkers incorporated within vaccine-laden baits in target species as representative of bait contact; serological measurement of the induction of specific rabies virus neutralizing antibodies, indicative of an immune response to vaccine; and most importantly, the decreasing detection of rabies virus antigens in the brains of collected animals via enhanced laboratory-based surveillance, as evidence of management impact. Although often conceived mistakenly as a panacea, such cost-effective technology applied to free-ranging wildlife represents a real-world, One Health application benefiting agriculture, conservation biology, and public health. Based upon lessons learned with oral rabies vaccination of mesocarnivores, opportunities for future extension to other taxa and additional diseases will have far-reaching, transdisciplinary benefits.
Collapse
Affiliation(s)
- Charles E Rupprecht
- College of Forestry, Wildlife and Environment, College of Veterinary Medicine, Auburn University, 602 Duncan Drive, Auburn, Alabama 36849, USA
| | - Tore Buchanan
- Wildlife Research and Monitoring Section, Ontario Ministry of Natural Resources and Forestry, Trent University, 2140 East Bank Drive, Peterborough, Ontario K9L1Z8, Canada
| | - Florence Cliquet
- ANSES, Nancy Laboratory for Rabies and Wildlife, European Union Reference Laboratory for Rabies Serology, European Union Reference Laboratory for Rabies, WHO Collaborating Centre for Research and Management in Zoonoses Control, WOAH Reference Laboratory for Rabies, Technopôle Agricole et Vétérinaire, Domaine de Pixérécourt, CS 40009 Malzeville, France
| | - Roni King
- Israel Nature and Parks Authority, Am V'Olamo 3, Jerusalem 95463, Israel
| | - Thomas Müller
- Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, WHO Collaborating Centre for Rabies Surveillance and Research, WOAH Reference Laboratory for Rabies, Südufer 10, 17493 Greifswald-Insel Riems, Germany
| | - Boris Yakobson
- WOAH Reference Laboratory for Rabies, Kimron Veterinary Institute, Ministry of Agriculture, Derech HaMaccabim 62, Rishon Lezion, 50250, Israel
| | - Dong-Kun Yang
- Viral Disease Division, Animal and Plant Quarantine Agency, Ministry of Agriculture, Food and Rural Affairs, 177, Hyeoksin 8-ro, Gimcheon-si, Gyeongsangbuk-do, 39660, Republic of Korea
| |
Collapse
|
2
|
Beasley EM, Nelson KM, Slate D, Gilbert AT, Pogmore FE, Chipman RB, Davis AJ. Oral Rabies Vaccination of Raccoons (Procyon lotor) across a Development Intensity Gradient in Burlington, Vermont, USA, 2015-2017. J Wildl Dis 2024; 60:1-13. [PMID: 37972639 DOI: 10.7589/jwd-d-22-00117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2022] [Accepted: 06/27/2022] [Indexed: 11/19/2023]
Abstract
Management of the raccoon rabies virus variant in North America is conducted primarily using oral rabies vaccination (ORV). When a sufficient proportion of the population is vaccinated (∼60%), rabies transmission can be eliminated. To date, ORV programs have successfully controlled and eliminated raccoon rabies in rural areas, but there has been less success in urban areas. We studied the proportions of rabies virus neutralizing antibodies (RVNA) in a raccoon (Procyon lotor) population during a 3-yr ORV trial in developed areas of Burlington, Vermont, US. We used a modified N-mixture model to estimate raccoon abundance, RVNA seroprevalence, and capture rates jointly to examine factors that relate to ORV success to better inform management. We found that raccoon abundance was lower in less-developed areas compared to urban centers. Raccoon RVNA seroprevalence decreased as population abundance increased; it increased as the average age of the population increased. Nontarget opossum (Didelphis virginiana) captures correlated with a decrease in raccoon RVNA seroprevalence in low-development areas, suggesting that they may be competing for baits. The target bait density across the entire study area was 150 baits/km2, but a hand baiting strategy was heavily concentrated on roads, resulting in uneven bait densities within sampling sites (0-484 baits/km2). Uneven bait distribution across the study area may explain low RVNA seroprevalence in some locations. Our results suggest that increases in bait density across the study area may improve RVNA seroprevalence and support annual ORV to account for raccoon population turnover.
Collapse
Affiliation(s)
- Emily M Beasley
- University of Vermont, Department of Biology, 109 Carrigan Drive, Burlington, Vermont 05401, USA
- Current affiliation: Université de Montréal, Département de Sciences Biologiques, 1375 Avenue Thérèse-Lavoie-Roux, Montréal, Quebec H2V 0B3, Canada
- These authors contributed equally
| | - Kathleen M Nelson
- United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Rabies Management Program, 59 Chenell Drive, Suite 2, Concord, New Hampshire 03301, USA
- These authors contributed equally
| | - Dennis Slate
- United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Rabies Management Program, 59 Chenell Drive, Suite 2, Concord, New Hampshire 03301, USA
- Current affiliation: Chippewa Bay Wildlife Art and Science LLC, 1132 County Road 6, Hammond, New York 13646, USA
| | - Amy T Gilbert
- United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center, 4101 Laporte Avenue, Fort Collins, Colorado 80521, USA
| | - Frederick E Pogmore
- United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, 617 Comstock Road, Suite 9, Berlin, Vermont 05602, USA
| | - Richard B Chipman
- United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Rabies Management Program, 59 Chenell Drive, Suite 2, Concord, New Hampshire 03301, USA
| | - Amy J Davis
- United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center, 4101 Laporte Avenue, Fort Collins, Colorado 80521, USA
| |
Collapse
|
3
|
Farnós O, Martins Fernandes Paes BC, Getachew B, Rourou S, Chaabene A, Gelaye E, Tefera TA, Kamen AA. Intranasally Delivered Adenoviral Vector Protects Chickens against Newcastle Disease Virus: Vaccine Manufacturing and Stability Assessments for Liquid and Lyophilized Formulations. Vaccines (Basel) 2023; 12:41. [PMID: 38250854 PMCID: PMC10819614 DOI: 10.3390/vaccines12010041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2023] [Revised: 12/08/2023] [Accepted: 12/20/2023] [Indexed: 01/23/2024] Open
Abstract
Newcastle disease (ND) remains a critical disease affecting poultry in sub-Saharan Africa. In some countries, repeated outbreaks have a major impact on local economies and food security. Recently, we developed an adenovirus-vectored vaccine encoding the Fusion protein from an Ethiopian isolate of Newcastle disease virus (NDV). The adenoviral vector was designed, and a manufacturing process was developed in the context of the Livestock Vaccine Innovation Fund initiative funded by the International Development Research Centre (IDRC) of Canada. The industrially relevant recombinant vaccine technology platform is being transferred to the National Veterinary Institute (Ethiopia) for veterinary applications. Here, a manufacturing process using HEK293SF suspension cells cultured in stirred-tank bioreactors for the vaccine production is proposed. Taking into consideration supply chain limitations, options for serum-free media selection were evaluated. A streamlined downstream process including a filtration, an ultrafiltration, and a concentration step was developed. With high volumetric yields (infectious titers up to 5 × 109 TCID50/mL) in the culture supernatant, the final formulations were prepared at 1010 TCID50/mL, either in liquid or lyophilized forms. The liquid formulation was suitable and safe for mucosal vaccination and was stable for 1 week at 37 °C. Both the liquid and lyophilized formulations were stable after 6 months of storage at 4 °C. We demonstrate that the instillation of the adenoviral vector through the nasal cavity can confer protection to chickens against a lethal challenge with NDV. Overall, a manufacturing process for the adenovirus-vectored vaccine was developed, and protective doses were determined using a convenient route of delivery. Formulation and storage conditions were established, and quality control protocols were implemented.
Collapse
Affiliation(s)
- Omar Farnós
- Viral Vectors and Vaccines Bioprocessing Group, Department of Bioengineering, McGill University, Montreal, QC H3A 0G4, Canada (B.C.M.F.P.)
| | | | - Belayneh Getachew
- Research and Development Directorate, National Veterinary Institute, Bishoftu P.O. Box 19, Ethiopia (E.G.); (T.A.T.)
| | - Samia Rourou
- Laboratory of Molecular Microbiology, Vaccinology and Biotechnology Development, Group of Biotechnology Development, Institut Pasteur de Tunis, Université Tunis El Manar, 13, Place Pasteur. BP.74., Tunis 1002, Tunisia; (S.R.)
| | - Ameni Chaabene
- Laboratory of Molecular Microbiology, Vaccinology and Biotechnology Development, Group of Biotechnology Development, Institut Pasteur de Tunis, Université Tunis El Manar, 13, Place Pasteur. BP.74., Tunis 1002, Tunisia; (S.R.)
| | - Esayas Gelaye
- Research and Development Directorate, National Veterinary Institute, Bishoftu P.O. Box 19, Ethiopia (E.G.); (T.A.T.)
| | - Takele A. Tefera
- Research and Development Directorate, National Veterinary Institute, Bishoftu P.O. Box 19, Ethiopia (E.G.); (T.A.T.)
| | - Amine A. Kamen
- Viral Vectors and Vaccines Bioprocessing Group, Department of Bioengineering, McGill University, Montreal, QC H3A 0G4, Canada (B.C.M.F.P.)
| |
Collapse
|
4
|
Dettinger L, Gigante CM, Sellard M, Seiders M, Patel P, Orciari LA, Yager P, Lute J, Regec A, Li Y, Xia D. Detection of Apparent Early Rabies Infection by LN34 Pan-Lyssavirus Real-Time RT-PCR Assay in Pennsylvania. Viruses 2022; 14:1845. [PMID: 36146650 PMCID: PMC9504839 DOI: 10.3390/v14091845] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2022] [Revised: 08/12/2022] [Accepted: 08/18/2022] [Indexed: 11/16/2022] Open
Abstract
The Pennsylvania Department of Health Bureau of Laboratories (PABOL) tested 6855 animal samples for rabies using both the direct fluorescent antibody test (DFA) and LN34 pan-lyssavirus reverse transcriptase quantitative PCR (RT-qPCR) during 2017-2019. Only two samples (0.03%) were initially DFA negative but positive by LN34 RT-qPCR. Both cases were confirmed positive upon re-testing at PABOL and confirmatory testing at the Centers for Disease Control and Prevention by LN34 RT-qPCR and DFA. Rabies virus sequences from one sample were distinct from all positive samples processed at PABOL within two weeks, ruling out cross-contamination. Levels of rabies virus antigen and RNA were low in all brain structures tested, but were higher in brain stem and rostral spinal cord than in cerebellum, hippocampus or cortex. Taken together, the low level of rabies virus combined with higher abundance in more caudal brain structures suggest early infection. These cases highlight the increased sensitivity and ease of interpretation of LN34 RT-qPCR for low positive cases.
Collapse
Affiliation(s)
- Lisa Dettinger
- Bureau of Laboratories, Pennsylvania Department of Health, Exton, PA 19341, USA
| | - Crystal M. Gigante
- Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA
| | - Maria Sellard
- Bureau of Laboratories, Pennsylvania Department of Health, Exton, PA 19341, USA
| | - Melanie Seiders
- Bureau of Laboratories, Pennsylvania Department of Health, Exton, PA 19341, USA
| | - Puja Patel
- Bureau of Laboratories, Pennsylvania Department of Health, Exton, PA 19341, USA
| | - Lillian A. Orciari
- Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA
| | - Pamela Yager
- Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA
| | - James Lute
- Bureau of Laboratories, Pennsylvania Department of Health, Exton, PA 19341, USA
| | - Annette Regec
- Bureau of Laboratories, Pennsylvania Department of Health, Exton, PA 19341, USA
| | - Yu Li
- Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA
| | - Dongxiang Xia
- Bureau of Laboratories, Pennsylvania Department of Health, Exton, PA 19341, USA
| |
Collapse
|
5
|
McClure KM, Bastille‐Rousseau G, Davis AJ, Stengel CA, Nelson KM, Chipman RB, Wittemyer G, Abdo Z, Gilbert AT, Pepin KM. Accounting for animal movement improves vaccination strategies against wildlife disease in heterogeneous landscapes. ECOLOGICAL APPLICATIONS : A PUBLICATION OF THE ECOLOGICAL SOCIETY OF AMERICA 2022; 32:e2568. [PMID: 35138667 PMCID: PMC9285612 DOI: 10.1002/eap.2568] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/25/2021] [Revised: 08/28/2021] [Accepted: 10/15/2021] [Indexed: 06/14/2023]
Abstract
Oral baiting is used to deliver vaccines to wildlife to prevent, control, and eliminate infectious diseases. A central challenge is how to spatially distribute baits to maximize encounters by target animal populations, particularly in urban and suburban areas where wildlife such as raccoons (Procyon lotor) are abundant and baits are delivered along roads. Methods from movement ecology that quantify movement and habitat selection could help to optimize baiting strategies by more effectively targeting wildlife populations across space. We developed a spatially explicit, individual-based model of raccoon movement and oral rabies vaccine seroconversion to examine whether and when baiting strategies that match raccoon movement patterns perform better than currently used baiting strategies in an oral rabies vaccination zone in greater Burlington, Vermont, USA. Habitat selection patterns estimated from locally radio-collared raccoons were used to parameterize movement simulations. We then used our simulations to estimate raccoon population rabies seroprevalence under currently used baiting strategies (actual baiting) relative to habitat selection-based baiting strategies (habitat baiting). We conducted simulations on the Burlington landscape and artificial landscapes that varied in heterogeneity relative to Burlington in the proportion and patch size of preferred habitats. We found that the benefits of habitat baiting strongly depended on the magnitude and variability of raccoon habitat selection and the degree of landscape heterogeneity within the baiting area. Habitat baiting improved seroprevalence over actual baiting for raccoons characterized as habitat specialists but not for raccoons that displayed weak habitat selection similar to radiocollared individuals, except when baits were delivered off roads where preferred habitat coverage and complexity was more pronounced. In contrast, in artificial landscapes with either more strongly juxtaposed favored habitats and/or higher proportions of favored habitats, habitat baiting performed better than actual baiting, even when raccoons displayed weak habitat preferences and where baiting was constrained to roads. Our results suggest that habitat selection-based baiting could increase raccoon population seroprevalence in urban-suburban areas, where practical, given the heterogeneity and availability of preferred habitat types in those areas. Our novel simulation approach provides a flexible framework to test alternative baiting strategies in multiclass landscapes to optimize bait-distribution strategies.
Collapse
Affiliation(s)
- Katherine M. McClure
- National Wildlife Research Center, Wildlife Services, Animal and Plant Health Inspection ServiceUnited States Department of AgricultureFort CollinsColoradoUSA
- Department of Microbiology, Immunology, and PathologyColorado State UniversityFort CollinsColoradoUSA
- Present address:
Hawai‘i Cooperative Studies UnitUniversity of Hawai‘i at HiloHiloHawai‘iUSA
| | - Guillaume Bastille‐Rousseau
- National Wildlife Research Center, Wildlife Services, Animal and Plant Health Inspection ServiceUnited States Department of AgricultureFort CollinsColoradoUSA
- Cooperative Wildlife Research LaboratorySouthern Illinois UniversityCarbondaleIllinoisUSA
| | - Amy J. Davis
- National Wildlife Research Center, Wildlife Services, Animal and Plant Health Inspection ServiceUnited States Department of AgricultureFort CollinsColoradoUSA
| | - Carolyn A. Stengel
- Wildlife Services, Animal and Plant Health Inspection ServiceUnited States Department of AgricultureConcordNew HampshireUSA
| | - Kathleen M. Nelson
- National Rabies Management Program, Wildlife Services, Animal and Plant Health Inspection ServiceUnited States Department of AgricultureConcordNew HampshireUSA
| | - Richard B. Chipman
- National Rabies Management Program, Wildlife Services, Animal and Plant Health Inspection ServiceUnited States Department of AgricultureConcordNew HampshireUSA
| | - George Wittemyer
- Fish, Wildlife, and Conservation BiologyColorado State UniversityFort CollinsColoradoUSA
| | - Zaid Abdo
- Department of Microbiology, Immunology, and PathologyColorado State UniversityFort CollinsColoradoUSA
| | - Amy T. Gilbert
- National Wildlife Research Center, Wildlife Services, Animal and Plant Health Inspection ServiceUnited States Department of AgricultureFort CollinsColoradoUSA
| | - Kim M. Pepin
- National Wildlife Research Center, Wildlife Services, Animal and Plant Health Inspection ServiceUnited States Department of AgricultureFort CollinsColoradoUSA
| |
Collapse
|
6
|
Oral Rabies Vaccination of Small Indian Mongooses ( Urva auropunctata) with ONRAB via Ultralite Baits. Viruses 2021; 13:v13050734. [PMID: 33922562 PMCID: PMC8144982 DOI: 10.3390/v13050734] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2021] [Revised: 04/09/2021] [Accepted: 04/20/2021] [Indexed: 11/23/2022] Open
Abstract
The Ontario Rabies Vaccine (ONRAB) is a human adenovirus rabies glycoprotein recombinant oral vaccine immunogenic for small Indian mongooses when delivered by direct instillation into the oral cavity. We offered Ultralite baits containing ~1.8 mL 109.5 TCID50 ONRAB oral rabies vaccine to 18 mongooses, while 6 mongooses were offered identical baits in placebo form. We collected sera from individual mongooses at days 0, 14 and 30 post vaccination (pv) and quantified rabies virus neutralizing antibodies (RVNA) using the rapid fluorescent focus inhibition test, with titers greater than or equal to 0.1 IU/mL considered positive. All study subjects were RVNA negative prior to bait offering. Bait consumption was variable: all 6 sham and 13 of 18 (72%) treatment animals consumed/punctured the baits offered. By day 30 pv, RVNA were detected among 11 of 13 (84.6%) of treatment mongooses that consumed/punctured baits, whereas sham-vaccinated mongooses remained RVNA negative throughout the study. We conclude ONRAB is immunogenic for mongooses by Ultralite bait delivery, although the bait design may need further optimization.
Collapse
|
7
|
Johnson SR, Slate D, Nelson KM, Davis AJ, Mills SA, Forbes JT, VerCauteren KC, Gilbert AT, Chipman RB. Serological Responses of Raccoons and Striped Skunks to Ontario Rabies Vaccine Bait in West Virginia during 2012-2016. Viruses 2021; 13:v13020157. [PMID: 33499059 PMCID: PMC7912576 DOI: 10.3390/v13020157] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2020] [Revised: 01/15/2021] [Accepted: 01/21/2021] [Indexed: 12/29/2022] Open
Abstract
Since the 1990s, oral rabies vaccination (ORV) has been used successfully to halt the westward spread of the raccoon rabies virus (RV) variant from the eastern continental USA. Elimination of raccoon RV from the eastern USA has proven challenging across targeted raccoon (Procyon lotor) and striped skunk (Mephitis mephitis) populations impacted by raccoon RV. Field trial evaluations of the Ontario Rabies Vaccine Bait (ONRAB) were initiated to expand ORV products available to meet the rabies management goal of raccoon RV elimination. This study describes the continuation of a 2011 trial in West Virginia. Our objective was to evaluate raccoon and skunk response to ORV occurring in West Virginia for an additional two years (2012–2013) at 75 baits/km2 followed by three years (2014–2016) of evaluation at 300 baits/km2. We measured the change in rabies virus-neutralizing antibody (RVNA) seroprevalence in targeted wildlife populations by comparing levels pre- and post-ORV during each year of study. The increase in bait density from 75/km2 to 300/km2 corresponded to an increase in average post-ORV seroprevalence for raccoon and skunk populations. Raccoon population RVNA levels increased from 53% (300/565, 95% CI: 50–57%) to 82.0% (596/727, 95% CI: 79–85%) during this study, and skunk population RVNA levels increased from 11% (8/72, 95% CI: 6–20%) to 39% (51/130, 95% CI: 31–48%). The RVNA seroprevalence pre-ORV demonstrated an increasing trend across study years for both bait densities and species, indicating that multiple years of ORV may be necessary to achieve and maintain RVNA seroprevalence in target wildlife populations for the control and elimination of raccoon RV in the eastern USA.
Collapse
Affiliation(s)
- Shylo R. Johnson
- USDA/APHIS/WS/National Wildlife Research Center, 4101 LaPorte Ave., Fort Collins, CO 80521, USA; (A.J.D.); (K.C.V.); (A.T.G.)
- Correspondence:
| | - Dennis Slate
- USDA/APHIS/WS/National Rabies Management Program, 59 Chenell Dr., Concord, NH 03301, USA; (D.S.); (K.M.N.); (R.B.C.)
| | - Kathleen M. Nelson
- USDA/APHIS/WS/National Rabies Management Program, 59 Chenell Dr., Concord, NH 03301, USA; (D.S.); (K.M.N.); (R.B.C.)
| | - Amy J. Davis
- USDA/APHIS/WS/National Wildlife Research Center, 4101 LaPorte Ave., Fort Collins, CO 80521, USA; (A.J.D.); (K.C.V.); (A.T.G.)
| | - Samual A. Mills
- USDA/APHIS/Wildlife Services, 730 Yokum St., Elkins, WV 26241, USA; (S.A.M.); (J.T.F.)
| | - John T. Forbes
- USDA/APHIS/Wildlife Services, 730 Yokum St., Elkins, WV 26241, USA; (S.A.M.); (J.T.F.)
| | - Kurt C. VerCauteren
- USDA/APHIS/WS/National Wildlife Research Center, 4101 LaPorte Ave., Fort Collins, CO 80521, USA; (A.J.D.); (K.C.V.); (A.T.G.)
| | - Amy T. Gilbert
- USDA/APHIS/WS/National Wildlife Research Center, 4101 LaPorte Ave., Fort Collins, CO 80521, USA; (A.J.D.); (K.C.V.); (A.T.G.)
| | - Richard B. Chipman
- USDA/APHIS/WS/National Rabies Management Program, 59 Chenell Dr., Concord, NH 03301, USA; (D.S.); (K.M.N.); (R.B.C.)
| |
Collapse
|
8
|
Slate D, Saidy BD, Simmons A, Nelson KM, Davis A, Algeo TP, Elmore SA, Chipman RB. Rabies Management Implications Based on Raccoon Population Density Indexes. J Wildl Manage 2020. [DOI: 10.1002/jwmg.21869] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Dennis Slate
- USDA, APHIS, Wildlife Services, National Rabies Management Program 59 Chenell Drive, Suite 2 Concord NH 03301 USA
| | - Brandi D. Saidy
- USDA, APHIS, Wildlife Services 2803 Jolly Road, Suite 100 Okemos MI 48864 USA
| | - Ashlee Simmons
- USDA, APHIS, Wildlife Services, National Rabies Management Program 59 Chenell Drive, Suite 2 Concord NH 03301 USA
| | - Kathleen M. Nelson
- USDA, APHIS, Wildlife Services, National Rabies Management Program 59 Chenell Drive, Suite 2 Concord NH 03301 USA
| | - Amy Davis
- USDA, APHIS, Wildlife Services, National Wildlife Research Center 4101 LaPorte Avenue Fort Collins CO 80521 USA
| | - Timothy P. Algeo
- USDA, APHIS, Wildlife Services, National Rabies Management Program 59 Chenell Drive, Suite 2 Concord NH 03301 USA
| | - Stacey A. Elmore
- USDA, APHIS, Wildlife Services, National Wildlife Research Center 4101 LaPorte Avenue Fort Collins CO 80521 USA
| | - Richard B. Chipman
- USDA, APHIS, Wildlife Services, National Rabies Management Program 59 Chenell Drive, Suite 2 Concord NH 03301 USA
| |
Collapse
|
9
|
Davis AJ, Nelson KM, Kirby JD, Wallace R, Ma X, Pepin KM, Chipman RB, Gilbert AT. Rabies Surveillance Identifies Potential Risk Corridors and Enables Management Evaluation. Viruses 2019; 11:E1006. [PMID: 31683632 PMCID: PMC6893774 DOI: 10.3390/v11111006] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2019] [Revised: 10/12/2019] [Accepted: 10/29/2019] [Indexed: 11/17/2022] Open
Abstract
Intensive efforts are being made to eliminate the raccoon variant of rabies virus (RABV) from the eastern United States and Canada. The United States Department of Agriculture (USDA) Wildlife Services National Rabies Management Program has implemented enhanced rabies surveillance (ERS) to improve case detection across the extent of the raccoon oral rabies vaccination (ORV) management area. We evaluated ERS and public health surveillance data from 2006 to 2017 in three northeastern USA states using a dynamic occupancy modeling approach. Our objectives were to examine potential risk corridors for RABV incursion from the U.S. into Canada, evaluate the effectiveness of ORV management strategies, and identify surveillance gaps. ORV management has resulted in a decrease in RABV cases over time within vaccination zones (from occupancy ( ψ ¯ ) of 0.60 standard error (SE) = 0.03 in the spring of 2006 to ψ ¯ of 0.33 SE = 0.10 in the spring 2017). RABV cases also reduced in the enzootic area (from ψ ¯ of 0.60 SE = 0.03 in the spring of 2006 to ψ ¯ of 0.45 SE = 0.05 in the spring 2017). Although RABV occurrence was related to habitat type, greater impacts were associated with ORV and trap-vaccinate-release (TVR) campaigns, in addition to seasonal and yearly trends. Reductions in RABV occupancy were more pronounced in areas treated with Ontario Rabies Vaccine Bait (ONRAB) compared to RABORAL V-RG®. Our approach tracked changes in RABV occurrence across space and time, identified risk corridors for potential incursions into Canada, and highlighted surveillance gaps, while evaluating the impacts of management actions. Using this approach, we are able to provide guidance for future RABV management.
Collapse
Affiliation(s)
- Amy J Davis
- National Wildlife Research Center, United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, Fort Collins, CO 80521, USA.
| | - Kathleen M Nelson
- National Rabies Management Program, United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, Concord, NH 03301-8548, USA.
| | - Jordona D Kirby
- National Rabies Management Program, United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, Concord, NH 03301-8548, USA.
| | - Ryan Wallace
- Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
| | - Xiaoyue Ma
- Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
| | - Kim M Pepin
- National Wildlife Research Center, United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, Fort Collins, CO 80521, USA.
| | - Richard B Chipman
- National Rabies Management Program, United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, Concord, NH 03301-8548, USA.
| | - Amy T Gilbert
- National Wildlife Research Center, United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, Fort Collins, CO 80521, USA.
| |
Collapse
|
10
|
Abstract
Oral rabies vaccination is the principal strategy used to control rabies in wildlife. No oral rabies vaccine is licensed for small Indian mongooses (Herpestes auropunctatus). The Ontario Rabies Vaccine Bait (ONRAB) is a human adenovirus type-5 rabies glycoprotein recombinant vaccine licensed for rabies control in striped skunks (Mephitis mephitis) in Canada and is under experimental evaluation in the US. We evaluated varying doses of ONRAB vaccine by direct instillation into the oral cavity with three groups of 10 mongooses: Group 1 received 109.5 TCID50, group 2 received 108.8 TCID50, and group 3 received 108.5 TCID50 of vaccine. Six control mongooses were sham-vaccinated with culture media. We collected a serum sample prior to vaccination and on days 14 and 30 postvaccination (PV). We quantified the level of rabies virus neutralizing antibodies (RVNA) from mongoose sera and compared titers among vaccinated groups and time points PV, where values greater than or equal to 0.1 IU/mL were considered positive. On day 14 PV, 87% (26 of 30, 95% confidence interval 70-95%) of vaccinates had seroconverted, whereas all vaccinates demonstrated RVNA by day 30 PV. There was a marginal effect of vaccine dose on group means of log-transformed RVNA titers at day 14 PV (F=2.5, P=0.099), but not day 30 PV. Sham-vaccinated animals were seronegative during all time points.
Collapse
|
11
|
Yang DK, Kim HH, Lee EJ, Yoo JY, Kim JT, Ahn S. Rabies immune status of raccoon dogs residing in areas where rabies bait vaccine has been distributed. Clin Exp Vaccine Res 2019; 8:132-135. [PMID: 31406695 PMCID: PMC6689503 DOI: 10.7774/cevr.2019.8.2.132] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2019] [Revised: 07/04/2019] [Accepted: 07/04/2019] [Indexed: 12/25/2022] Open
Abstract
Since 2000, large amounts of rabies bait vaccine have been distributed in two provinces where raccoon dog-mediated rabies has occurred. A total of 146 raccoon dogs were caught in Gangwon and Gyeonggi Provinces from January 2017 to June 2018, and raccoon dog blood samples were collected. Of the 146 raccoon dogs, 13.7% (20/146) had rabies antibodies. In Gyeonggi and Gangwon provinces, the rate of rabies antibody was 8.5% (5/59) and 17.2% (15/87), respectively. Considering these results, it would be desirable to improve the distribution method or use a new bait vaccine to prevent animal rabies in South Korea.
Collapse
Affiliation(s)
- Dong-Kun Yang
- Viral Disease Research Division, Animal and Plant Quarantine Agency, Ministry of Agriculture, Food and Rural Affairs, Gimcheon, Korea
| | - Ha-Hyun Kim
- Viral Disease Research Division, Animal and Plant Quarantine Agency, Ministry of Agriculture, Food and Rural Affairs, Gimcheon, Korea
| | - Eun-Jin Lee
- Viral Disease Research Division, Animal and Plant Quarantine Agency, Ministry of Agriculture, Food and Rural Affairs, Gimcheon, Korea
| | - Jae-Young Yoo
- Viral Disease Research Division, Animal and Plant Quarantine Agency, Ministry of Agriculture, Food and Rural Affairs, Gimcheon, Korea
| | - Jong-Taek Kim
- College of Veterinary Medicine, Kangwon National University, Chuncheon, Korea
| | - Sangjin Ahn
- College of Veterinary Medicine, Kangwon National University, Chuncheon, Korea
| |
Collapse
|
12
|
Sobey KG, Jamieson SE, Walpole AA, Rosatte RC, Donovan D, Fehlner-Gardiner C, Nadin-Davis SA, Davies JC, Kyle CJ. ONRAB® oral rabies vaccine is shed from, but does not persist in, captive mammals. Vaccine 2019; 37:4310-4317. [PMID: 31248686 DOI: 10.1016/j.vaccine.2019.06.046] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2019] [Revised: 06/13/2019] [Accepted: 06/14/2019] [Indexed: 10/26/2022]
Abstract
ONRAB® is a human adenovirus rabies glycoprotein recombinant vaccine developed to control rabies in wildlife. To support licensing and widespread use of the vaccine, safety studies are needed to assess its potential residual impact on wildlife populations. We examined the persistence of the ONRAB® vaccine virus in captive rabies vector and non-target mammals. This research complements work on important rabies vector species (raccoon, striped skunk, and red fox) but also adds to previous findings with the addition of some non-target species (Virginia opossum, Norway rats, and cotton rats) and a prolonged period of post vaccination monitoring (41 days). Animals were directly inoculated orally with the vaccine and vaccine shedding was monitored using quantitative real-time PCR applied to oral and rectal swabs. ONRAB® DNA was detected in both oral and rectal swabs from 6 h to 3 days post-inoculation in most animals, followed by a resurgence of shedding between days 17 and 34 in some species. Overall, the duration over which ONRAB® DNA was detectable was shorter for non-target mammals, and by day 41, no animal had detectable DNA in either oral or rectal swabs. All target species, as well as cotton rats and laboratory-bred Norway rats, developed robust humoral immune responses as measured by competitive ELISA, with all individuals being seropositive at day 31. Similarly, opossums showed good response (89% seropositive; 8/9), whereas only one of nine wild caught Norway rats was seropositive at day 31. These results support findings of other safety studies suggesting that ONRAB® does not persist in vector and non-target mammals exposed to the vaccine. As such, we interpret these data to reflect a low risk of adverse effects to wild populations following distribution of ONRAB® to control sylvatic rabies.
Collapse
Affiliation(s)
- Kirk G Sobey
- Wildlife Research and Monitoring Section, Ontario Ministry of Natural Resources and Forestry, 2140 East Bank Drive, Trent University, Peterborough, Ontario K9L 0G2, Canada
| | - Sarah E Jamieson
- Wildlife Research and Monitoring Section, Ontario Ministry of Natural Resources and Forestry, 2140 East Bank Drive, Trent University, Peterborough, Ontario K9L 0G2, Canada.
| | - Aaron A Walpole
- Wildlife Section, Ontario Ministry of Natural Resources and Forestry, 300 Water Street, Peterborough, Ontario K9J 8M5, Canada.
| | - Rick C Rosatte
- Wildlife Research and Monitoring Section, Ontario Ministry of Natural Resources and Forestry, 2140 East Bank Drive, Trent University, Peterborough, Ontario K9L 0G2, Canada.
| | - Dennis Donovan
- Wildlife Research and Monitoring Section, Ontario Ministry of Natural Resources and Forestry, 2140 East Bank Drive, Trent University, Peterborough, Ontario K9L 0G2, Canada.
| | - Christine Fehlner-Gardiner
- Canadian Food Inspection Agency, Ottawa Laboratory Fallowfield, PO Box 11300, Station H, Nepean, Ontario K2H 8P9, Canada.
| | - Susan A Nadin-Davis
- Canadian Food Inspection Agency, Ottawa Laboratory Fallowfield, PO Box 11300, Station H, Nepean, Ontario K2H 8P9, Canada.
| | - J Chris Davies
- Wildlife Research and Monitoring Section, Ontario Ministry of Natural Resources and Forestry, 2140 East Bank Drive, Trent University, Peterborough, Ontario K9L 0G2, Canada.
| | - Christopher J Kyle
- Natural Resources DNA Profiling and Forensics Centre, 2140 East Bank Drive, DNA Building, Trent University, Peterborough, Ontario K9J 7B8, Canada.
| |
Collapse
|
13
|
Feline herpesvirus vectored-rabies vaccine in cats: A dual protection. Vaccine 2019; 37:2224-2231. [PMID: 30878247 DOI: 10.1016/j.vaccine.2019.03.008] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2019] [Revised: 03/02/2019] [Accepted: 03/05/2019] [Indexed: 01/01/2023]
Abstract
In China, cats cause about 5% of human rabies cases. Rabies control in cats plays a role in achieving the ultimate goal of elimination of dog rabies-mediated human deaths. However, there is no cat-specific rabies vaccine in China yet. In this study, we constructed a recombinant rabies vaccine by using a felid herpesvirus 1 (FHV-1) isolate, and deleted the gI/E in the FHV-1 and replaced the region with a glycoprotein (G) of rabies virus (RABV) strain BD06 through homologous recombination. The recombinant virus FHV-RVG was recovered and purified, and the expression of RABV glycoprotein was verified by indirect immunofluorescent assay. For potency in cats, each animal was inoculated intranasally with 1 ml FHV-RVG at 106.5 TCID50. Blood samples were collected at defined intervals for antibody titration. The animals were challenged by herpes and rabies after completion of vaccination on day 180 and day 194, respectively. Our results demonstrated all vaccinated cats generated antibodies against both FHV-1 and RABV, and reached an arbitrary protective titer > 0.5 IU/ml for rabies viral neutralizing antibody (VNA) by day 14 post inoculation (dpi) and titer peaked on 30 dpi with VNA at 24.5 ± 10.23 IU/ml. All vaccinated cats presented no clinical signs of FHV-1 infection and survived rabies challenge, while the control cats had severe rhinotracheitis and died from rabies after challenge. All this demonstrated that the FHV-based recombinant vaccine is effective in protection against both FHV-1 and RABV infections.
Collapse
|
14
|
RACCOON ( PROCYON LOTOR) RESPONSE TO ONTARIO RABIES VACCINE BAITS (ONRAB) IN ST. LAWRENCE COUNTY, NEW YORK, USA. J Wildl Dis 2019; 55:645-653. [PMID: 30620627 DOI: 10.7589/2018-09-216] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Oral rabies vaccination (ORV) campaigns have been conducted annually in the US over the past two decades to prevent raccoon (Procyon lotor) rabies, which is enzootic along the eastern region of the country from southeastern Canada to Alabama. Because raccoon rabies has been eliminated from neighboring Canadian provinces, continued detection of the variant in the US is of concern due to the potential for infected raccoons to cross the border via the St. Lawrence River. Ontario Rabies Vaccine Baits (ONRAB) containing a live, recombinant human adenovirus expressing the rabies virus glycoprotein have been under experimental use in the US since 2011. We distributed ONRAB in St. Lawrence County, New York, from 2013 to 2015 as part of field trials to evaluate serologic responses in raccoons. Prior to ONRAB distribution, rabies virus neutralizing antibody (RVNA) seroprevalence in raccoons was 45.2% (183 of 405) and increased to 57.7% (165 of 286) after 3 yr of ONRAB baiting. Postbait RVNA seroprevalence increased each year, with a lower response observed in juvenile compared with adult raccoons. The pre-ONRAB seroprevalence detected in 2013 was relatively high and was likely impacted both by elevated rabies activity in the county and the use of ORV with a different vaccine bait for 14 consecutive years prior to our study. Tetracycline biomarker prevalence increased from 1.4% prior to ONRAB baiting to 51.3% from 2013 to 2015, demonstrating bait palatability to raccoons. These data complemented related field trials conducted in West Virginia and the northeastern US.
Collapse
|